Shingrix was originally approved by the FDA in 2017 for the prevention of shingles in adults 50 years and older. Now, it’s approved for those 18 years and older who are immunocompromised.
Armand Butera
Advertisement
Articles by Armand Butera
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Infection Control Today
1
Sterile Processing Under Pressure: What Penn State Health’s Instrument Sterilization Crisis Reveals About Patient Safety Risks
2
Hantavirus Outbreak on an Atlantic Cruise Ship: Facts, Figures and Public Health Implications
3
UV-C as a Critical Second Step in Reducing HAIs: Why Adjunct Disinfection Is a Strategic Investment in High-Risk Health Care Environments
4
Infectious Disease Doctor Discusses Hantavirus Outbreak and Public Health Preparedness, Misinformation, and Emerging Disease Threats
5